Biotrin IgG and IgM EIAs Approvable For Parvovirus B19 And Fifth Disease
This article was originally published in The Gray Sheet
Executive Summary
Biotrin International's IgG and IgM enzyme immunoassays (EIAs) should be approved for detection of antibodies to Parvovirus B19 and serologic diagnosis of Fifth disease, FDA's Microbiology Devices panel unanimously recommended May 21.